Tesamorelin
Description
Tesamorelin is a stabilized GHRH analog with a longer half-life and stronger receptor affinity than sermorelin. It has been studied specifically for its effects on visceral adipose tissue and body composition in clinical research settings, making it the GHRH analog of choice in metabolic and body-composition research protocols. Its stability profile allows for less frequent administration in research models. Each vial is lyophilized to pharmaceutical-grade purity. For research and laboratory use only.
